Here are four takeaways:
1. The company recently reported good first quarter financial results, up from the same period in 2015.
2. Approximately 4.77 million shares traded hands, up 87.8 percent from the average.
3. Since Oct. 5, 2015, the company has decreased 27.03 percent.
4. Cytori has underperformed the S&P500 by 31.92 percent.
More articles on devices:
Exactech insider sells 3.9k shares — 4 notes
4 trends in outpatient spine surgery from Amendia
Xtant Medical CEO buys company shares worth $11k+: 4 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
